Le Lézard
Classified in: Health, Science and technology

Space-Made Fibers and Novel Biotech Among Research Returning to Earth After Successful Space Station Mission


SpaceX's 30th Commercial Resupply Services Mission for NASA returns to Earth after more than 35 days onboard the International Space Station

KENNEDY SPACE CENTER, Fla., April 30, 2024 /PRNewswire/ -- Research on a novel vision loss therapy and space-manufactured optical fibers were among the nearly 565 pounds of science and technology payloads sponsored by the International Space Station (ISS) National Laboratory that splashed down off the Florida coast Tuesday morning as NASA concluded SpaceX's 30th Commercial Resupply Services (CRS) mission.

The return of the SpaceX Dragon capsule brings back more than 40 ISS National Lab-sponsored investigations that aim to benefit humanity and foster commerce in low Earth orbit. Among the payloads returning to Earth for analysis are the following:

These are just a few of the investigations returning to Earth in the SpaceX Dragon capsule on this mission. To learn more about all of the ISS National Lab payloads on SpaceX CRS-30, please visit our launch page.

To download a high-resolution photo for this release, click here. 

About the International Space Station (ISS) National Laboratory:
The International Space Station (ISS) is a one-of-a-kind laboratory that enables research and technology development not possible on Earth. As a public service enterprise, the ISS National Laboratory® allows researchers to leverage this multiuser facility to improve quality of life on Earth, mature space-based business models, advance science literacy in the future workforce, and expand a sustainable and scalable market in low Earth orbit. Through this orbiting national laboratory, research resources on the ISS are available to support non-NASA science, technology, and education initiatives from U.S. government agencies, academic institutions, and the private sector. The Center for the Advancement of Science in Spacetm (CASIStm) manages the ISS National Lab, under Cooperative Agreement with NASA, facilitating access to its permanent microgravity research environment, a powerful vantage point in low Earth orbit, and the extreme and varied conditions of space. To learn more about the ISS National Lab, visit our website.

As a 501(c)(3) nonprofit organization, CASIS accepts corporate and individual donations to help advance science in space for the benefit of humanity. For more information, visit our donations page.

Media Contact:         

Patrick O'Neill 


904-806-0035 


[email protected]


International Space Station (ISS) National Laboratory
Managed by the Center for the Advancement of Science in Space, Inc. (CASIS)

6905 N. Wickham Rd., Suite 500, Melbourne, FL 32940 ? 321.253.5101 ? www.ISSNationalLab.org

 

SOURCE International Space Station National Lab


These press releases may also interest you

at 06:20
KAYTUS, a leading IT infrastructure provider, introduced at ISC High Performance 2024 its high-density computing server KR1280V2. It supports 32 E1.S SSDs, achieving an impressive flash memory density of 512TB in a 1U form factor. Compared to the...

at 06:15
Epson today announced the SureColor® F1070 hybrid printing solution is now available. Ideal for garment decorators, entrepreneurs, artisan businesses, and print service providers, the easy-to-use printer is purpose built for both direct-to-garment...

at 06:07
An optimal vaginal microbiome is a key driver of gynecological, urogenital, and reproductive health  VS-01tm is a multi-strain probiotic and prebiotic clinically validated to establish an optimal vaginal microbiome and sustain regulated vaginal pH...

at 06:05
With 5.7 million electric vehicles (EVs) anticipated to be used in fleet applications by 2025, EV Connect, a leading EV charging business platform, and bp pulse, a global leader in charging infrastructure for fleets and public charging, today...

at 06:05
Cigent® Technology, Inc., the leader in cybersecurity for endpoints and storage devices, today announced the Cigent Endpoint Data Protection Platform that protects data from ransomware, data exfiltration, and data loss. The Endpoint Data Protection...

at 06:05
Ironwood Pharmaceuticals, Inc. , a GI-focused healthcare company, will present late-breaking data during the 2024 Digestive Disease Week® (DDW) meeting from its pivotal Phase III clinical trial, STARS, which evaluated the efficacy and safety of...



News published on and distributed by: